Diuretic Resistance in Heart Failure
Purpose of Review
Diuretic resistance (DR) occurs along a spectrum of relative severity and contributes to worsening of acute heart failure (AHF) during an inpatient stay. This review gives an overview of mechanisms of DR with a focus on loop diuretics and summarizes the current literature regarding the prognostic value of diuretic efficiency and predictors of natriuretic response in AHF.
The pharmacokinetics of diuretics are impaired in chronic heart failure, but little is known about mechanisms of DR in AHF. Almost all diuresis after administration of a loop diuretic dose occurs in the first few hours after administration and within-dose DR can develop. Recent studies suggest that DR at the level of the nephron may be more important than defects in diuretic delivery to the tubule. Because loop diuretics induce natriuresis, urine sodium (UNa) concentration may serve as a functional, physiological, and direct measure for diuretic responsiveness to a given loop diuretic dose.
Identifying and targeting individuals with DR for more aggressive, tailored therapy represents an important opportunity to improve outcomes. A better understanding of the mechanistic underpinnings of DR in AHF is needed to identify additional biomarkers and guide future trials and therapies.
KeywordsAcute heart failure Loop diuretics Diuretic resistance Spot urine sodium Biomarkers
Compliance with Ethical Standards
Conflict of Interest
Richa Gupta declares no conflicts of interest.
Jeffrey Testani received consultancy fees and/or research grants from AstraZeneca, Boehringer Ingelheim, Sanofi, Abbott, FIRE1, Sequana Medical, Otsuka, Bristol Myers Squibb, Reprieve Medical, Cardionomic, and 3ive labs.
Sean Collins received consultancy fees and/or research grants from Novartis, Vixiar, Ortho Clinical, NIH, AHRQ, PCORI, DOD, AHA, and CREAVO.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
- 3.Ambrosy AP, Pang PS, Khan S, Konstam MA, Fonarow GC, Traver B, et al. Clinical course and predictive value of congestion during hospitalization in patients admitted for worsening signs and symptoms of heart failure with reduced ejection fraction: findings from the EVEREST trial. Eur Heart J. 2013;34:835–43.CrossRefGoogle Scholar
- 4.Gheorghiade M, Follath F, Ponikowski P, Barsuk JH, Blair JE, Cleland JG, et al. Assessing and grading congestion in acute heart failure: a scientific statement from the acute heart failure committee of the heart failure Association of the European Society of cardiology and endorsed by the European Society of Intensive Care Medicine. Eur J Heart Fail. 2010;12:423–33.CrossRefGoogle Scholar
- 6.Lala A, McNulty SE, Mentz RJ, Dunlay SM, Vader JM, AbouEzzeddine OF, et al. Relief and recurrence of congestion during and after hospitalization for acute heart failure: insights from diuretic optimization strategy evaluation in acute decompensated heart failure (DOSE-AHF) and cardiorenal rescue study in acute decompensated heart failure (CARESS-HF). Circ Heart Fail. 2015;8:741–8.CrossRefGoogle Scholar
- 12.•• Testani JM, Brisco MA, Turner JM, Spatz ES, Bellumkonda L, Parikh CR, et al. Loop diuretic efficiency: a metric of diuretic responsiveness with prognostic importance in acute decompensated heart failure. Circ Heart Fail. 2014;7:261–70. This was the first study to define the concept of diuretic efficiency (DE) or the efficiency with which diuretic can facilitate diuresis and natriuresis. This study also showed that DE can capture prognostic information beyond raw fluid output or diuretic dose and is independently associated with survival. The authors also found no association between glomerular filtration rate and DE, suggesting that renal function and drug delivery or pharmacokinetics may be less important drivers of DE. CrossRefGoogle Scholar
- 13.• Valente MA, Voors AA, Damman K, Van Veldhuisen DJ, Massie BM, O’Connor CM, et al. Diuretic response in acute heart failure: clinical characteristics and prognostic significance. Eur Heart J. 2014;35:1284–93. This was one of the first studies to show that worse diuretic response was associated with more advanced heart failure among other adverse clinical conditions and predicts mortality and heart failure rehospitalizations. CrossRefGoogle Scholar
- 18.Hoorn EJ, Wilcox CS, Ellison DH. Diuretics. In: Skorecki K, Chertow GM, Marsden PA, Taal MW, Yu ASL, editors. Brenner and Rector’s the kidney. 10th ed. Philadelphia: Elsevier; 2016. p. 1702–33.Google Scholar
- 19.Murray MD, Haag KM, Black PK, Hall SD, Brater DC, et al. Variable furosemide absorption and poor predictability of response in elderly patients. Pharmacotherapy. 1997;17:98–106.Google Scholar
- 22.Uwai Y, Saito H, Hashimoto Y, Inui KI. Interaction and transport of thiazide diuretics, loop diuretics, and acetazolamide via rat renal organic anion transporter rOAT1. J Pharmacol Exp Ther. 2000;295:261–5.Google Scholar
- 23.Chennavasin P, Seiwell R, Brater DC. Pharmacokinetic-dynamic analysis of the indomethacin-furosemide interaction in man. J Pharmacol Exp Ther. 1980;215:77–81.Google Scholar
- 26.Besseghir K, Mosig D, Roch-Ramel F. Facilitation by serum albumin of renal tubular secretion of organic ions. Am J Phys. 1989;256:F475–84.Google Scholar
- 29.Wilcox CS. New insights into diuretic use in patients with chronic renal disease. J Am Soc Nephrol. 2002;13:798–805.Google Scholar
- 33.• Shah S, Pitt B, Brater DC, Feig PU, Shen W, Khwaja FS, et al. Sodium and fluid excretion with torsemide in healthy subjects is limited by the short duration of diuretic action. J Am Heart Assoc. 2017;6:e006135. This study demonstrated the development of severe within-dose development of diuretic resistance (DR), providing some of the first evidence to suggest that DR at the level of the nephron, rather than pharmacokinetics, is important in dictating diuretic duration of action. Google Scholar
- 34.• Ter Maaten JM, Rao VS, Hanberg JS, Wilson FP, Bellumkonda L, Assefa M, et al. Renal tubular resistance is the primary driver for loop diuretic resistance in acute heart failure. Eur J Heart Fail. 2017;19:1014–22. This study highlights the importance of renal tubular defects in driving DR in acute heart failure. CrossRefGoogle Scholar
- 38.Metra M, Cotter G, Senger S, Edwards C, Cleland JG, Ponikowski P, et al. Prognostic significance of creatinine increases during an acute heart failure admission in patients with and without residual congestion: a post hoc analysis of the PROTECT data. Circ Heart Fail. 2018;11:e004644.CrossRefGoogle Scholar
- 47.• Kiernan MS, Stevens SR, WHW T, Butler J, Anstrom K, Birati EY, et al. Determinants of diuretic responsiveness and associated outcomes during acute heart failure hospitalization: an analysis from the NHLBI Heart Failure Network clinical trials. J Card Fail. 2018;24:428–38. This study defined DE as total 72-hour fluid output per total loop diuretic dose; lower DE was a marker of heart failure disease severity and associated with reduced survival. Poor diuretic response was associated with poor clinical markers. CrossRefGoogle Scholar
- 48.Garg LC, Kapturczak M. Renal compensatory response to hydrochlorothiazide changes Na-K-ATPase in distal nephron. In: Puschett JB, Greenberg A, editors. Diuretics II: chemistry, pharmacology, and clinical applications: proceedings of the Second International Conference on Diuretics, held June 22–27, 1986. Cascais: Elsevier Science Ltd.; 1987. p. 188–94.Google Scholar
- 49.Kaissling B, Bachmann S, Kriz W. Structural adaptation of the distal convoluted tubule to prolonged furosemide treatment. Am J Phys. 1985;248:F374–81.Google Scholar
- 51.Wilcox CS, Mitch WE, Kelly RA, Skorecki K, Meyer TW, Friedman PA, et al. Response of the kidney to furosemide. I. Effects of salt intake and renal compensation. J Lab Clin Med. 1983;102:450–8.Google Scholar
- 54.Wilcox CS, Loon NR, Kanthawatana S, Pham MA, Cannizzaro R. Generation of alkalosis with loop diuretics: roles of contraction and acid excretion. J Nephrol. 1991;2:81–7.Google Scholar
- 56.• Singh D, Shrestha K, Testani JM, Verbrugge FH, Dupont M, Mullens W, et al. Insufficient natriuretic response to continuous intravenous furosemide is associated with poor long-term outcomes in acute decompensated heart failure. J Card Fail. 2014;20:392–9. Describes urinary sodium (UNa) as a predictor of clinical outcomes or natriuretic response. Described in text and Table 2. CrossRefGoogle Scholar
- 57.• Ferreira JP, Girerd N, Medeiros PB, Santos M, Carvalho HC, Bettencourt P, et al. Spot urine sodium excretion as prognostic marker in acutely decompensated heart failure: the spironolactone effect. Clin Res Cardiol. 2016;105:489–507. Describes UNa as a predictor of clinical outcomes or natriuretic response. Described in text and Table 2. CrossRefGoogle Scholar
- 58.• Luk A, Groarke JD, Desai AS, Mahmood SS, Gopal DM, Joyce E, et al. First spot urine sodium after initial diuretic identifies patients at high risk for adverse outcome after heart failure hospitalization. Am Heart J. 2018;203:95–100. Describes UNa as a predictor of clinical outcomes or natriuretic response. Described in text and Table 2. CrossRefGoogle Scholar
- 59.• Testani JM, Hanberg JS, Cheng S, Rao V, Onyebeke C, Laur O, et al. Rapid and highly accurate prediction of poor loop diuretic natriuretic response in patients with heart failure. Circ Heart Fail. 2016;9:e002370. Describes UNa as a predictor of clinical outcomes or natriuretic response. Described in text and Table 2. CrossRefGoogle Scholar
- 60.• Brinkley DM, Burpee LJ, Chaudhry S, Smallwood JA, Lindenfeld J, Lakdawala NK, et al. Spot urine sodium as triage for effective diuretic infusion in an ambulatory heart failure unit. J Card Fail. 2018;24:349–54. Describes UNa as a predictor of clinical outcomes or natriuretic response. Described in text and Table 2. CrossRefGoogle Scholar
- 61.• Collins SC, Jenkins CA, Baughman A, Miller KF, Storrow A, Han JH, et al. Early urine electrolyte patterns are associated with in-hospital worsening heart failure in emergency department patients with acute heart failure. ESC Heart Fail. 2018. Describes UNa as a predictor of clinical outcomes or natriuretic response Described in text and Table 2. Google Scholar
- 62.• Mullens W, Damman K, Harjola V, Mebazaa A, Brunner-La Rocca H, Martens P, et al. The use of diuretics in heart failure with congestion—a position statement from the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail. 2019. https://doi.org/10.1002/ejhf.1369. This is a recent, important expert opinion/position paper focusing on the practical use of diuretics in AHF with congestion.